How "immunomodulatory" are IMIDs?

@article{Mitsiades2011HowA,
  title={How "immunomodulatory" are IMIDs?},
  author={Constantine Mitsiades},
  journal={Blood},
  year={2011},
  volume={117 5},
  pages={1440-1}
}
In this issue of Blood, Hsu and colleagues report that the immunostimulatory effect of lenalidomide on natural killer (NK)–cell function is profoundly suppressed by concurrent dexamethasone (Dex) therapy in multiple myeloma (MM) patients. These results could have major implications for the design of clinical trials combining lenalidomide and immunotherapies with the intent to stimulate the anti-MM activity of the latter. 

From This Paper

Topics from this paper.

References

Publications referenced by this paper.
Showing 1-10 of 16 references

Lenalidomide maintenance after transplantation for myeloma [abstract

  • M Attal, C Cristini, G Marit
  • J Clin Oncol
  • 2010

Phase III intergroup study of lenalidomide versus placebo mainte nance therapy following single autologous stem cell transplant (ASCT) for multiple myeloma (MM): CALGB 100104 [abstract

  • PL McCarthy, K Owzar, KC Anderson
  • J Clin Oncol
  • 2010

Similar Papers

Loading similar papers…